Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Lantern Pharma Inc.
DescriptionSemisynthetic sesquiterpene derivative of illudin S, a natural toxin isolated from the fungus Omphalotus illudens
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat metastatic castration resistant prostate cancer
Regulatory Designation
PartnerOncology Venture ApS

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today